We are live on ! Find out more
SI

Scharf Investments Portfolio holdings

AUM $3.03B
1-Year Est. Return 7.75%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$3.17B
AUM Growth
-$125M
Cap. Flow
-$67.7M
Cap. Flow %
-2.14%
Top 10 Hldgs %
56.23%
Holding
51
New
2
Increased
22
Reduced
22
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$56.2M
2
FISV
Fiserv Inc
FISV
+$42M
3
VVV icon
Valvoline
VVV
+$16.9M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16M
5
MLKN icon
MillerKnoll
MLKN
+$10.7M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$84.1M
2
DGX icon
Quest Diagnostics
DGX
+$40M
3
MSFT icon
Microsoft
MSFT
+$29.9M
4
ORCL icon
Oracle
ORCL
+$20M
5
KSU
Kansas City Southern
KSU
+$7.16M

Sector Composition

Rank Sector Weight
1 Healthcare 24.87%
2 Technology 21.44%
3 Financials 14.59%
4 Consumer Discretionary 12.14%
5 Communication Services 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$267M 8.43%
946,937
-102,855
-10% -$29.9M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$213M 6.73%
781,304
-7,926
-1% -$2.23M
AAP icon
3
Advance Auto Parts
AAP
$3.35B
$178M 5.6%
850,066
-8,214
-1% -$1.71M
CMCSA icon
4
Comcast
CMCSA
$85B
$177M 5.59%
3,170,457
-52,136
-2% -$3.04M
MCK icon
5
McKesson
MCK
$100B
$174M 5.48%
871,579
+6,171
+0.7% +$1.23M
CVS icon
6
CVS Health
CVS
$133B
$169M 5.32%
1,987,330
-14,794
-0.7% -$1.24M
ORCL icon
7
Oracle
ORCL
$374B
$166M 5.25%
1,908,245
-226,524
-11% -$20M
MKL icon
8
Markel Group
MKL
$23.3B
$154M 4.86%
128,692
-1,170
-0.9% -$1.44M
LBRDK icon
9
Liberty Broadband Class C
LBRDK
$4.88B
$143M 4.52%
829,642
-9,395
-1% -$1.69M
VVV icon
10
Valvoline
VVV
$4.9B
$141M 4.45%
4,518,560
+544,139
+14% +$16.9M
CNC icon
11
Centene
CNC
$30.7B
$127M 3.99%
2,030,913
-39,824
-2% -$2.66M
FISV
12
Fiserv Inc
FISV
$28.8B
$126M 3.99%
1,165,563
+376,199
+48% +$42M
MAS icon
13
Masco
MAS
$14.1B
$126M 3.98%
2,270,024
-66,094
-3% -$3.92M
LMT icon
14
Lockheed Martin
LMT
$134B
$123M 3.9%
357,725
-11,854
-3% -$4.29M
JNJ icon
15
Johnson & Johnson
JNJ
$618B
$121M 3.8%
746,555
-18,668
-2% -$3.18M
CTSH icon
16
Cognizant
CTSH
$24.9B
$109M 3.45%
1,471,555
-15,602
-1% -$1.15M
NVS icon
17
Novartis
NVS
$297B
$102M 3.21%
1,244,711
-17,882
-1% -$1.61M
UL icon
18
Unilever
UL
$137B
$95.7M 3.02%
1,568,592
-17,146
-1% -$1.09M
PGR icon
19
Progressive
PGR
$123B
$90.1M 2.84%
996,950
-9,163
-0.9% -$873K
MLKN icon
20
MillerKnoll
MLKN
$1.53B
$60.8M 1.92%
1,613,908
+250,078
+18% +$10.7M
AZN icon
21
AstraZeneca
AZN
$263B
$58M 1.83%
+483,015
New +$56.2M
KSU
22
DELISTED
Kansas City Southern
KSU
$56.4M 1.78%
208,412
-25,730
-11% -$7.16M
BIDU icon
23
Baidu
BIDU
$37.7B
$55.5M 1.75%
360,829
-10,092
-3% -$1.66M
J icon
24
Jacobs Solutions
J
$15.9B
$51.6M 1.63%
470,635
-10,582
-2% -$1.17M
DGX icon
25
Quest Diagnostics
DGX
$25.7B
$35M 1.1%
240,648
-273,105
-53% -$40M
1
2 3

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
MB
MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return

Scharf Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Scharf Investments held 51 positions worth $3.17B, down 3.8% from $3.29B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Scharf Investments's Q3 2021 filing shows 2 new, 22 increased, 22 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 483,015 shares worth $58M. The largest sale was Alexion Pharmaceuticals, an estimated $84.1M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Scharf Investments's largest Q3 2021 buy was AstraZeneca: 483,015 shares worth $58M.
  • Scharf Investments added most to Fiserv Inc in Q3 2021, an estimated $42M increase.
  • Scharf Investments's biggest Q3 2021 reduction was Quest Diagnostics, cutting an estimated $40M.
  • Scharf Investments fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $84.1M.
  • Scharf Investments's ten largest holdings make up 56% of its $3.17B portfolio in Q3 2021.
  • Scharf Investments opened 2 new positions and closed 3 in Q3 2021.
  • Scharf Investments's portfolio value fell 3.8% quarter-over-quarter to $3.17B.

Based on Scharf Investments's 13F filing for Q3 2021, filed 14 Oct 2021.